Fundraising Fox
Poseida Therapeutics
San Diego, US · Founded 2014 · Delaware corporation · 18,294 employees on LinkedIn · 4 known investors
Find your way into Poseida Therapeutics
Sign up to see every warm intro you have to Poseida Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Poseida Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications. The company was acquired by Roche, with its programs now developed by Genentech.
Founders & leadership
Poseida Therapeutics was founded in 2014 by Eric Ostertag.
Board
Investors · 4
How we know: Aisling Capital's portfolio page · funding news · Not right? Tell us
How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Rapha Capital Management, LLC's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$231.8M disclosed across 5 of 7 rounds · 2015–2023
▶$25MraisedAug 2023 · 1 investors · BiotechnologyRule 506(b)
- Harry J. LeonhardtExecutive Officer
- Mark J. GergenExecutive Officer, Director
- Johanna M. MyletExecutive Officer
- Luke CorningDirector
- Cynthia CollinsDirector
- Marcea B. LloydDirector
- Brent WarnerExecutive Officer
- Charles M. BaumDirector
- Kristin YaremaExecutive Officer
- John SchmidDirector
- Rafael AmadoDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$142.1MraisedApr 2019 · 17 investors · BiotechnologyRule 506(b)
- John SchmidDirector
- Noah BerkowitzDirector
- Marcea Bland LloydDirector
- Eric OstertagExecutive Officer, Director
- David HirschDirector
- Catherine J. MackeyDirector
- Sean MurphyDirector
- Mark GergenExecutive Officer, Director
- Matthew SpearExecutive Officer
- Offering amount
- $150M
- Amount sold
- $142.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$30.5MraisedApr 2018 · 7 investors · BiotechnologyRule 506(b)
- Adrian HowdDirector
- Eric OstertagExecutive Officer, Director
- Mark GergenExecutive Officer, Director
- David HirschDirector
- Offering amount
- $30.5M
- Amount sold
- $30.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$11.2MraisedAug 2017 · 16 investors · BiotechnologyRule 506(b)
- Adrian HowdDirector
- Eric OstertagExecutive Officer, Director
- Robert LyonsDirector
- Lars EkmanDirector
- Nishan de SilvaExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $11.2M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$23MraisedDec 2015 · 14 investors · BiotechnologyRule 506(b)
- Eric OstertagExecutive Officer, Director
- Nishan de SilvaExecutive Officer, Director
- Lars EkmanDirector
- Offering amount
- $36M
- Amount sold
- $23M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Poseida Therapeutics do?
- Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications. The company was acquired by Roche, with its programs now developed by Genentech.
- Who founded Poseida Therapeutics?
- Poseida Therapeutics was founded by Eric Ostertag in 2014.
- Who are Poseida Therapeutics's investors?
- Poseida Therapeutics's investors include Aisling Capital, Longitude Capital, Rapha Capital Management, LLC, Vivo Capital.
- How much funding has Poseida Therapeutics raised?
- Poseida Therapeutics has disclosed $231.8M raised across 5 of its 7 known rounds.
- Where is Poseida Therapeutics headquartered?
- Poseida Therapeutics is headquartered in San Diego, US.